You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for Patent: 5,034,394


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,034,394
Title: Therapeutic nucleosides
Abstract:The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. Also provided are pharmaceutical formulations and processes for the preparation of compounds according to the invention.
Inventor(s): Daluge; Susan M. (Chapel Hill, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:07/455,201
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Composition; Formulation;

Drugs Protected by US Patent 5,034,394

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,034,394

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8815265Jun 27, 1988

International Family Members for US Patent 5,034,394

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0434450 ⤷  Sign Up SPC/GB99/032 United Kingdom ⤷  Sign Up
European Patent Office 0434450 ⤷  Sign Up C990028 Netherlands ⤷  Sign Up
European Patent Office 0434450 ⤷  Sign Up 33/1999 Austria ⤷  Sign Up
European Patent Office 0434450 ⤷  Sign Up 1999C0033 Belgium ⤷  Sign Up
European Patent Office 0434450 ⤷  Sign Up 990028 Netherlands ⤷  Sign Up
African Regional IP Organization (ARIPO) 101 ⤷  Sign Up
African Regional IP Organization (ARIPO) 196 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.